Dopamine as a potential diagnostic biomarker in women's sexual dysfunction

Area of Science:

• Endocrinology
• Neuroscience
• Reproductive Health

Background:

• Dopamine and prolactin are crucial for sexual function.
• The specific role of dopamine in female sexual dysfunction (FSD) remains unclear.
• Investigating dopamine's relationship with sex hormones and prolactin in FSD is essential.

Purpose of the Study:

• To explore the role of dopamine in FSD among Egyptian women.
• To examine the association between dopamine, sex steroid hormones (estrogen, progesterone, DHEA), and prolactin levels in women with FSD.

Main Methods:

• A comparative study involving 84 women with FSD and 84 controls.
• Assessment of demographic, gynecological data, and female sexual function index (FSFI) scores.
• Measurement of serum estradiol, progesterone, DHEA, prolactin, and dopamine levels.

Main Results:

• FSD patients exhibited significantly lower dopamine and estradiol levels.
• FSD patients showed significantly higher progesterone, DHEA, and prolactin levels.
• Low dopamine (≤8.8 ng/mL) was a significant predictor of FSD with high accuracy (83%).

Conclusions:

• Low serum dopamine levels may serve as a diagnostic biomarker for FSD.
• Dopamine dysfunction is associated with imbalances in prolactin and sex steroid hormones in FSD.
• Further research into dopamine's role can inform targeted FSD treatments.